Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Cervical Intraepithelial Neoplasia Grade 2/3 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 361Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cytological Techniques × Clear all
NCT03366493 2017-12-08

The Study of Folate Receptor-Mediated Staining Solution (FRDâ„¢) In Cervical Lesion Detection

GY Highland Biotech LLC

Phase 3 Unknown
200 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

Data powered by HemOnc (CC BY 4.0) Colophon âš¡